Zenas BioPharma, Inc.

ZBIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$51-$52-$34-$53
Dep. & Amort.$0-$1$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$6$5$5
Change in WC-$4$5-$9$9
Other Non-Cash$14$0-$0-$0
Operating Cash Flow-$41-$42-$37-$39
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$59-$127-$99-$10
Inv. Sales/Matur.$104$14$13$6
Other Inv. Act.-$5$0$0$0
Investing Cash Flow$40-$112-$86-$4
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$2$0$6
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$72$0$0-$4
Financing Cash Flow$73$2$0$2
Forex Effect$0-$0-$0$0
Net Chg. in Cash$72-$153-$123-$40
Supplemental Information
Beg. Cash$44$197$320$360
End Cash$116$44$197$320
Free Cash Flow-$41-$42-$37-$39
Zenas BioPharma, Inc. (ZBIO) Financial Statements & Key Stats | AlphaPilot